v3.8.0.1
Consolidated Statements of Changes in Equity - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
Comprehensive (Loss) Income [Member]
Accumulated Other Noncontrolling Interests [Member]
Total
Balance at Mar. 31, 2015 $ 1,571,877 $ 162,626,893 $ (143,361,711) $ (2,285,925) $ 2,543,529 $ 21,094,663
Balance, shares at Mar. 31, 2015 157,187,658          
Prior-period revision to inventory   (2,341,648) (2,341,648)
Net (loss) income   (2,516,368) 809,662 (1,706,706)
Foreign currency translation adjustment       92,131   92,131
Issuance of common stock, net of issuance costs of $124,876 $ 21,193 3,105,920 3,127,113
Issuance of common stock, net of issuance costs of $124,876, shares 2,119,282          
Exercise of common stock options $ 10,796 364,184 374,980
Exercise of common stock options, shares 1,079,602          
Common stock issued under 2013 incentive compensation plan $ 882 119,118 120,000
Common stock issued under 2013 incentive compensation plan, shares 88,235          
Subsidiary dividend paid to non-controlling interests (600,000) (600,000)
Stock-based compensation 1,250,556 1,250,556
Common stock issued in connection with the acquisition of an additional 20.1% of noncontrolling interests          
Balance at Mar. 31, 2016 $ 1,604,748 166,866,671 (148,219,727) (2,193,794) 3,353,191 21,411,089
Balance, shares at Mar. 31, 2016 160,474,777          
Net (loss) income     (852,613)   1,359,145 506,532
Foreign currency translation adjustment       (114,878)   (114,878)
Issuance of common stock, net of issuance costs of $124,876   (14,355)       (14,355)
Exercise of common stock options $ 6,710 244,479 251,189
Exercise of common stock options, shares 671,028          
Stock-based compensation   1,577,994 1,577,994
Common stock issued in connection with the acquisition of an additional 20.1% of noncontrolling interests $ 18,000 2,430,000 2,448,000
Common stock issued in connection with the acquisition of an additional 20.1% of noncontrolling interests, shares 1,800,000          
Effect of acquisition of an additional 20.1% of noncontrolling interests   (20,215,176) (2,232,824) (22,448,000)
Balance at Mar. 31, 2017 $ 1,629,458 150,889,613 (149,072,340) (2,308,672) 2,479,512 3,617,571
Balance, shares at Mar. 31, 2017 162,945,805          
Net (loss) income (818,932) 1,089,124 270,192
Foreign currency translation adjustment 226,661 226,661
Exercise of common stock options $ 3,567 231,696 235,263
Exercise of common stock options, shares 356,700          
Common stock issued under 2013 incentive compensation plan $ 329 32,943 33,272
Common stock issued under 2013 incentive compensation plan, shares 32,894          
Stock-based compensation 1,974,745 1,974,745
Common stock issued in connection with the acquisition of an additional 20.1% of noncontrolling interests          
Restricted share grants $ 11,820 (11,820)      
Restricted share grants, shares 1,182,000          
Conversion of 5% Convertible Notes to common stock $ 18,133 1,613,867 $ 1,632,000
Conversion of 5% Convertible Notes to common stock, shares 1,813,334         1,813,334
Balance at Mar. 31, 2018 $ 1,663,307 $ 154,731,044 $ (149,891,272) $ (2,082,011) $ 3,568,636 $ 7,989,704
Balance, shares at Mar. 31, 2018 166,330,733